Alan P. Wolffe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alan P. Wolffe has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
A. El-Osta
Laboratory of Molecular Embryology, National Institute of Child Heath and Human Development, NIH, Bethesda, MD 20892-5431, USA
1 shared publicationAnton Bauer
Sangamo Biosciences, Point Richmond Technology Centre, 501 Canal Boulevard, Suite A100, Richmond, CA 94804, 2Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, National Institutes of Health, Building 18T, Room 106, Bethesda, MD 20892, USA and 5Institute of Molecular Pathology, Dr. Bohr-Gasse 7, Vienna A-1030, Austria
1 shared publicationFyodor D Urnov
Sangamo Biosciences, Pt. Richmond Tech. Centre, 501 Canal Blvd., Suite A100, Richmond, CA 94804, USA
1 shared publicationFyodor D. Urnov
Sangamo Biosciences, Point Richmond Technology Centre, 501 Canal Boulevard, Suite A100, Richmond, CA 94804, USA
1 shared publicationHartmut Beug
Sangamo Biosciences, Point Richmond Technology Centre, 501 Canal Boulevard, Suite A100, Richmond, CA 94804, 2Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, National Institutes of Health, Building 18T, Room 106, Bethesda, MD 20892, USA and 5Institute of Molecular Pathology, Dr. Bohr-Gasse 7, Vienna A-1030, Austria
1 shared publicationJanet Yee
Sangamo Biosciences, Point Richmond Technology Centre, 501 Canal Boulevard, Suite A100, Richmond, CA 94804, 2Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, National Institutes of Health, Building 18T, Room 106, Bethesda, MD 20892, USA and 5Institute of Molecular Pathology, Dr. Bohr-Gasse 7, Vienna A-1030, Austria
1 shared publication
Latest Publications
- 1 May 2001
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 37, 45-57
Transcriptional regulation in the context of chromatin structure
A wide variety of histone-like proteins can be assembled into nucleosomal structures. Core and linker histone variants, proteins of the histone-fold and winged-helix families can all contribute to the local differentiation of functional chromosomal domains. It is very difficult to disrupt core histone interactions within a nucleosome in vivo. Histones H3 and H4 do not exchange out of chromatin outside S-phase. Histones H2A and H2B do exchange out of chromatin, but do so predominantly during transcription. This confers stability on the nucleosome during the cell cycle. Linker histones have a much less stable association with nucleosomal DNA, allowing for reversible activation of transcription. A distinct feature of histone interactions with nucleosomal DNA is the exposure of DNA on the surface of the nucleosome. One side of DNA is occluded on the histone surface, but the other is exposed and potentially accessible to other regulatory proteins. A major contributory factor to the functional specialization of chromatin is the capacity to target nucleosome modification and disruption.
- 1 May 2001
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 37, 45-57
Transcriptional regulation in the context of chromatin structure
A wide variety of histone-like proteins can be assembled into nucleosomal structures. Core and linker histone variants, proteins of the histone-fold and winged-helix families can all contribute to the local differentiation of functional chromosomal domains. It is very difficult to disrupt core histone interactions within a nucleosome in vivo. Histones H3 and H4 do not exchange out of chromatin outside S-phase. Histones H2A and H2B do exchange out of chromatin, but do so predominantly during transcription. This confers stability on the nucleosome during the cell cycle. Linker histones have a much less stable association with nucleosomal DNA, allowing for reversible activation of transcription. A distinct feature of histone interactions with nucleosomal DNA is the exposure of DNA on the surface of the nucleosome. One side of DNA is occluded on the histone surface, but the other is exposed and potentially accessible to other regulatory proteins. A major contributory factor to the functional specialization of chromatin is the capacity to target nucleosome modification and disruption.
- 1 April 2001
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 11 (2) , 121-123
Chromosomes and expression mechanisms The post-genomic era of gene control
- 1 April 2001
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 11 (2) , 121-123
Chromosomes and expression mechanisms The post-genomic era of gene control
- 1 January 2001
- Published by Xia & He Publishing in Gene Expression
- Vol. 9 (1) , 63-75
DNA Methylation and Histone Deacetylation in the Control of Gene Expression: Basic Biochemistry to Human Development and Disease
DNA methylation is a major determinant in the epigenetic silencing of genes. The mechanisms underlying the targeting of DNA methylation and the subsequent repression of transcription are relevant to human development and disease, as well as for attempts at somatic gene therapy. The success of transgenic technologies in plants and animals is also compromised by DNA methylation-dependent silencing pathways. Recent biochemical experiments provide a mechanistic foundation for understanding the influence of DNA methylation on transcription. The DNA methyltransferase Dnmt1, and several methyl-CpG binding proteins, MeCP2, MBD2, and MBD3, all associate with histone deacetylase. These observations firmly connect DNA methylation with chromatin modifications. They also provide new pathways for the potential targeting of DNA methylation to repressive chromatin as well as the assembly of repressive chromatin on methylated DNA. Here we discuss the implications of the methylation–acetylation connection for human cancers and the developmental syndromes Fragile X and Rett, which involve a mistargeting of DNA methylation-dependent repression.
- 1 January 2001
- Published by Xia & He Publishing in Gene Expression
- Vol. 9 (1) , 63-75
DNA Methylation and Histone Deacetylation in the Control of Gene Expression: Basic Biochemistry to Human Development and Disease
DNA methylation is a major determinant in the epigenetic silencing of genes. The mechanisms underlying the targeting of DNA methylation and the subsequent repression of transcription are relevant to human development and disease, as well as for attempts at somatic gene therapy. The success of transgenic technologies in plants and animals is also compromised by DNA methylation-dependent silencing pathways. Recent biochemical experiments provide a mechanistic foundation for understanding the influence of DNA methylation on transcription. The DNA methyltransferase Dnmt1, and several methyl-CpG binding proteins, MeCP2, MBD2, and MBD3, all associate with histone deacetylase. These observations firmly connect DNA methylation with chromatin modifications. They also provide new pathways for the potential targeting of DNA methylation to repressive chromatin as well as the assembly of repressive chromatin on methylated DNA. Here we discuss the implications of the methylation–acetylation connection for human cancers and the developmental syndromes Fragile X and Rett, which involve a mistargeting of DNA methylation-dependent repression.
- 1 October 2000
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 4 (5) , 665-685
Chromatin organisation and human disease
Targeted alterations in the nucleoprotein fibre of chromatin represent a major mechanism of gene control in eukarya, and the aetiology of a large number of human pathological conditions has been traced to molecular lesions in various components of chromatin-based gene regulatory pathways. In this review, those aspects of chromatin structure that are most immediately relevant to transcriptional control are briefly described, highlighting the various types of chromatin structure modification and disruption that occur in vivo and describing, in some detail, the biochemical and functional properties of the various molecular machines that effect such modification and disruption. In addition, a synthetic scenario for their involvement in the sequence of events that take place during gene repression and activation in vivo will be provided. After a description of the major clinical features and underlying molecular lesions in a number of human disorders with a known ‘chromatin-based’ aetiology, including various ...
- 1 October 2000
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 4 (5) , 665-685
Chromatin organisation and human disease
Targeted alterations in the nucleoprotein fibre of chromatin represent a major mechanism of gene control in eukarya, and the aetiology of a large number of human pathological conditions has been traced to molecular lesions in various components of chromatin-based gene regulatory pathways. In this review, those aspects of chromatin structure that are most immediately relevant to transcriptional control are briefly described, highlighting the various types of chromatin structure modification and disruption that occur in vivo and describing, in some detail, the biochemical and functional properties of the various molecular machines that effect such modification and disruption. In addition, a synthetic scenario for their involvement in the sequence of events that take place during gene repression and activation in vivo will be provided. After a description of the major clinical features and underlying molecular lesions in a number of human disorders with a known ‘chromatin-based’ aetiology, including various ...
- Open Access
- 1 August 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (15) , 4074-4090
Targeting of N‐CoR and histone deacetylase 3 by the oncoprotein v‐ErbA yields a chromatin infrastructure‐dependent transcriptional repression pathway
Transcriptional repression by nuclear hormone receptors is thought to result from a unison of targeting chromatin modification and disabling the basal transcriptional machinery. We used Xenopus oocytes to compare silencing effected by the thyroid hormone receptor (TR) and its mutated version, the oncoprotein v‐ErbA, on partly and fully chromatinized TR‐responsive templates in vivo. Repression by v‐ErbA was not as efficient as that mediated by TR, was significantly more sensitive to histone deacetylase (HDAC) inhibitor treatment and, unlike TR, v‐ErbA required mature chromatin to effect repression. We find that both v‐ErbA and TR can recruit the corepressor N‐CoR, but, in contrast to existing models, show a concomitant enrichment for HDAC3 that occurs without an association with Sin3, HDAC1/RPD3, Mi‐2 or HDAC5. We propose a requirement for chromatin infrastructure in N‐CoR/HDAC3‐effected repression and suggest that the inability of v‐ErbA to silence on partly chromatinized templates may stem from its impaired capacity to interfere with basal transcriptional machinery function. In support of this notion, we find v‐ErbA to be less competent than TR for binding to TFIIB in vitro and in vivo.
- 1 August 2000
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (15) , 4074-4090
Open AccessTargeting of N‐CoR and histone deacetylase 3 by the oncoprotein v‐ErbA yields a chromatin infrastructure‐dependent transcriptional repression pathway
Transcriptional repression by nuclear hormone receptors is thought to result from a unison of targeting chromatin modification and disabling the basal transcriptional machinery. We used Xenopus oocytes to compare silencing effected by the thyroid hormone receptor (TR) and its mutated version, the oncoprotein v‐ErbA, on partly and fully chromatinized TR‐responsive templates in vivo. Repression by v‐ErbA was not as efficient as that mediated by TR, was significantly more sensitive to histone deacetylase (HDAC) inhibitor treatment and, unlike TR, v‐ErbA required mature chromatin to effect repression. We find that both v‐ErbA and TR can recruit the corepressor N‐CoR, but, in contrast to existing models, show a concomitant enrichment for HDAC3 that occurs without an association with Sin3, HDAC1/RPD3, Mi‐2 or HDAC5. We propose a requirement for chromatin infrastructure in N‐CoR/HDAC3‐effected repression and suggest that the inability of v‐ErbA to silence on partly chromatinized templates may stem from its impaired capacity to interfere with basal transcriptional machinery function. In support of this notion, we find v‐ErbA to be less competent than TR for binding to TFIIB in vitro and in vivo.
- 1 June 2000
- Published by Elsevier in Current Biology
- Vol. 10 (12) , R463-R465
Transcriptional control: Imprinting insulation
- 1 June 2000
- Published by Elsevier in Current Biology
- Vol. 10 (12) , R463-R465
Transcriptional control: Imprinting insulation